targeted sequencing
Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Genetic Testing
The partners will design multiple assay kits in an attempt to make genetic testing for rare diseases more accessible to patients.
Genetron Health, Siemens Healthineers Partner to Promote Lung Cancer Molecular Testing in China
The companies will work together to increase adoption of Genetron's sequencing platform and lung cancer diagnostic assay in Chinese hospitals.
Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China
The deal to create a comprehensive genomic profiling test for Illumina's NextSeq 550Dx comes months after the instrument received regulatory approval in China.
Burning Rock Q4 Revenues Rise 50 Percent
Despite challenges related to the coronavirus pandemic, the Chinese precision oncology firm reported total quarterly revenues of RMB131.7 million ($20.2 million).
Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use
The company is working to expand access to its liquid biopsy assay outside of the US, after receiving US Food and Drug Administration approval last year.
Nov 24, 2020
Tempus Gets CE Mark for xT Tumor Sequencing Assay
May 12, 2020
Adaptive Biotechnologies Q1 Revenues Grow 65 Percent
Mar 10, 2020
Fulgent Genetics Q4 Revenues Grow 48 Percent
Mar 6, 2020